Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. 2020
  2. Published

    Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017

    Helleberg, M., Cho, D., Ekenberg, C., Sørensen, S., Rix, M., Gustafsson, Finn, Rasmussen, A., Perch, Michael, Andersen, P. H. S., Lundgren, Jens & Andersen, A. B., 2020, In: Tuberculosis research and treatment. 2020, 7 p., 7636975.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines

    Phillips, A. N., Bansi-Matharu, L., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D. R., Wensing, A., Lundgren, J. D., Pillay, D., Mellors, J., Cambiano, V., Jahn, A., Apollo, T., Mugurungi, O., Ripin, D., Da Silva, J., Raizes, E., Ford, N., Siberry, G. K., Gupta, R. K. & 5 others, Barnabas, R., Revill, P., Cohn, J., Calmy, A. & Bertagnolio, S., 2020, In: The Lancet HIV. 7, 3, p. e193-e200

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy

    Dimopoulou, C., Lundgren, Jens, Sundal, J., Ullum, H., Aukrust, P., Nielsen, Finn Cilius & Marvig, R. L., 2020, In: Journal of Human Genetics. 65, 3, p. 325-335 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

    Neesgaard, B., Mocroft, A., Zangerle, R., Wit, F., Lampe, F., Günthard, H. F., Necsoi, C., Law, M., Mussini, C., Castagna, A., Monforte, A. DA., Pradier, C., Chkhartisvilli, N., Reyes-Uruena, J., Vehreschild, J. J., Wasmuth, J-C., Sönnerborg, A., Stephan, C., Greenberg, L., Llibre, J. M. & 16 others, Volny-Anne, A., Peters, L., Pelchen-Matthews, A., Vannappagari, V., Gallant, J., Rieger, A., Youle, M., Braun, D., De Wit, S., Petoumenos, K., Borghi, V., Spagnuolo, V., Tsertsvadze, T., Lundgren, Jens, Ryom, L. & RESPOND Study Group, R. S. G., 2020, In: PLoS ONE. 15, 12, 19 p., e0243625.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2019
  7. Published

    "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"

    Wareham, N. E., Li, Q., Sengeløv, Henrik, Da Cunha-Bang, C., Gustafsson, Finn, Heilmann, C., Perch, Michael, Rasmussen, A., Sørensen, Søren Schwartz, Mocroft, A. & Lundgren, Jens, Dec 2019, In: Journal of Cancer Research and Clinical Oncology. 145, 12, p. 3125-3135 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

    D:A:D Study Group, D. S. G., Aug 2019, In: EClinicalMedicine. 13, p. 91-100 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    PARTNER Study Group, P. S. G., 15 Jun 2019, In: Lancet Oncology. 393, 10189, p. 2428-2438 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

    INSIGHT START Study Group, I. S. S. G., Jun 2019, In: Journal of the International AIDS Society. 22, 6, 10 p., e25297.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial

    INSIGHT START Study Group, I. S. S. G., 1 May 2019, In: Journal of acquired immune deficiency syndromes (1999). 81, 1, p. 10-17

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

    Ilett, E. E., Helleberg, M., Reekie, J., Murray, D. D., Wulff, S. M., Khurana, Mark Poulsen, Mocroft, A., Daugaard, G., Perch, Michael, Rasmussen, A., Sørensen, Søren Schwartz, Gustafsson, Finn, Frimodt-møller, N., Sengeløv, Henrik & Lundgren, Jens, 1 Apr 2019, In: Open Forum Infectious Diseases. 6, 4, 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13961